ROS-Driven PKCζ Signaling as a Widely Involved Mechanism for Cancer Cell Motility and Metastasis.
Saved in:
| Title: | ROS-Driven PKCζ Signaling as a Widely Involved Mechanism for Cancer Cell Motility and Metastasis. |
|---|---|
| Authors: | Sato Y; Department of Gastroenterology and Oncology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan.; 4th Department of Internal Medicine; Renamed as Department of Clinical Oncology, Sapporo Medical University, School of Medicine, Sapporo, Japan., Tanaka M; 4th Department of Internal Medicine; Renamed as Department of Clinical Oncology, Sapporo Medical University, School of Medicine, Sapporo, Japan.; Department of Clinical Laboratory Science, School of Medical Technology, Health Sciences University of Hokkaido, Sapporo, Japan., Kitamura N; Department of Molecular Target Exploration, Sapporo Medical University, School of Medicine, Sapporo, Japan., Araki N; 4th Department of Internal Medicine; Renamed as Department of Clinical Oncology, Sapporo Medical University, School of Medicine, Sapporo, Japan., Kurata W; Clinical Cancer Research Division, Shonan Research Institute of Innovative Medicine, Shonan Kamakura General Hospital, Shonan Health Innovation Park, Fujisawa, Japan., Sasaki A; Clinical Cancer Research Division, Shonan Research Institute of Innovative Medicine, Shonan Kamakura General Hospital, Shonan Health Innovation Park, Fujisawa, Japan., Seo Y; Clinical Cancer Research Division, Shonan Research Institute of Innovative Medicine, Shonan Kamakura General Hospital, Shonan Health Innovation Park, Fujisawa, Japan., Kuribayashi K; 4th Department of Internal Medicine; Renamed as Department of Clinical Oncology, Sapporo Medical University, School of Medicine, Sapporo, Japan., Kobayashi S; Clinical Cancer Research Division, Shonan Research Institute of Innovative Medicine, Shonan Kamakura General Hospital, Shonan Health Innovation Park, Fujisawa, Japan., Niitsu Y; Department of Molecular Target Exploration, Sapporo Medical University, School of Medicine, Sapporo, Japan.; Clinical Cancer Research Division, Shonan Research Institute of Innovative Medicine, Shonan Kamakura General Hospital, Shonan Health Innovation Park, Fujisawa, Japan. |
| Source: | Cancer science [Cancer Sci] 2025 Nov; Vol. 116 (11), pp. 3027-3039. Date of Electronic Publication: 2025 Aug 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1349-7006 |
|---|---|
| DOI: | 10.1111/cas.70165 |
